A COVID-19 vaccine developed jointly by a Taiwanese biomedical company and the United States National Institutes of Health (NIH) has been given conditional approval to enter human trials, Taiwan's Food and Drug Administration (FDA) said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Advantech to acquire French POS, KIOSK brand
04/29/2024 05:15 PM - Sports
Chen Yi-tung becomes first Taiwan male Olympic fencer in 36 years
04/29/2024 04:36 PM - Business
U.S. dollar closes lower on Taipei forex market
04/29/2024 04:24 PM - Business
Taiwan seeks to up agricultural exports to U.S. as trade talks begin
04/29/2024 02:15 PM - Business
Taiwan shares end up 1.86%
04/29/2024 01:53 PM